Valorisations sectorielles Lineage Cell Therapeutics, Inc.
Actions
LCTX
US53566P1093
Recherche biotechnologique et médicale
|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 1,320 USD | -0,75 % |
|
+0,76 % | -20,96 % |
| 13/05 | Transcript : Lineage Cell Therapeutics, Inc., Q1 2026 Earnings Call, May 12, 2026 | |
| 12/05 | Lineage Cell Therapeutics, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026 | CI |
Principaux concurrents
Ajouter à une liste 0 sélectionné | PER (N) | Price to Book (N) | PEG (N) | VE / CA (N) | VE / EBITDA (N) | VE / EBIT (N) | Rendement du dividende (N) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | -18.86x | - | 0.25x | - | - | - | - | 329 M | |
| 34.53x | 4.38x | 1.49x | 6.07x | 18.77x | 26.05x | 0,95 % | 49,74 Md | |
| -23.85x | 18.75x | -0.7x | 349.22x | -22.56x | -21.84x | -.--% | 40,49 Md | |
| 47.3x | 6.92x | 0.3x | 4.68x | 29.91x | 35.32x | -.--% | 34,35 Md | |
| 25.34x | 4.8x | 5.26x | 2.8x | 12.11x | 18.45x | -.--% | 34,75 Md | |
| 27.63x | 2.19x | 0.61x | 7.94x | 19.87x | 23.06x | 0,41 % | 26,98 Md | |
| 32.22x | 16.06x | 2.94x | 5.2x | 23.7x | 24.85x | -.--% | 15,6 Md | |
| -24.06x | 356.54x | -0.47x | 15.69x | -23.46x | -22.55x | -.--% | 14,27 Md | |
| 23.93x | 2.51x | 0.82x | 2.04x | 8.96x | 14.17x | 1,12 % | 13,76 Md | |
| 23.88x | 1.33x | 0.17x | 1.9x | 11.51x | 13.07x | -.--% | 12,92 Md | |
| -34.69x | 10.52x | 1.43x | 133.33x | -37.95x | -66.04x | -.--% | 12,49 Md | |
| 37.28x | 3.34x | -0.12x | 3.33x | 12.96x | 15.75x | -.--% | 11,01 Md | |
| 60.61x | 5.07x | 0.4x | 9.05x | 25.71x | 28.1x | 0,45 % | 11 Md | |
| -30.08x | 26.63x | -0.72x | 7.17x | 176.13x | -552.31x | -.--% | 10,79 Md | |
| -30.94x | 8.95x | -13.59x | 993.2x | -26.33x | -25.8x | -.--% | 10,01 Md | |
| -33.85x | 8.72x | 7.47x | 100.27x | -22.5x | -21.69x | -.--% | 9,81 Md | |
| -144.19x | 4.99x | 1.14x | 5.62x | 29.8x | 170.38x | -.--% | 9,2 Md | |
| -21.31x | 8.06x | -1.66x | 2485.85x | -18.02x | -17.12x | -.--% | 9,03 Md | |
| 35.97x | - | -0.12x | 16.63x | 29.69x | 32.16x | -.--% | 9,06 Md | |
| Moyenne | -0,69x | 28,81x | 0,26x | 230,55x | 13,79x | -18,11x | 0,16 % | 17,66 Md | |
| Moyenne pondérée par Capi. | 9,77x | 23,40x | 0,75x | 151,30x | 12,11x | -5,22x | 0,23 % |
- Bourse
- Actions
- Action LCTX
- Secteur Lineage Cell Therapeutics, Inc.
- Valorisations sectorielles
Choisissez Zonebourse 🔇
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
